Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 170   

Articles published

BMY 53.97 -0.42 (-0.77%)
price chart
The Bristol-Myers Squibb Co (BMY) Shares Sold by Huntington National Bank
Bristol-Myers Squibb Company Profile Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products.
Bristol-Myers Squibb Company (NYSE:BMY) Has Stock More Room to Run  ExpertGazette
Bristol-Myers Squibb Co (BMY) Position Boosted by Carroll Financial ...  Sports Perspectives
Citizens & Northern Corp Buys Bristol-Myers Squibb Company, Oracle Corp, WW ...
Citizens & Northern Corp initiated holdings in Bristol-Myers Squibb Company. The purchase prices were between $46.82 and $60.13, with an estimated average price of $54.85.
Still Some Uncertainty Surrounding Bristol-Myers Squibb
Bristol-Myers Squibb's stock has inched up a little following its Q1 2017 earnings release last week, as the company reported better than expected results. Its key cancer drug Opdivo grew nearly 60% despite competitive challenges, and blood thinner ...
Bristol-Myers Squibb: Dividend Cut Is Inevitable  Seeking Alpha
Bristol-Myers Squibb Co (BMY): Downgrading To Underperform  Smаrt Stоck Nеws
U.S. Food and Drug Administration Accepts for Priority Review Bristol-Myers ...
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced that the U.S. Food and Drug Administration (FDA) accepted a supplemental Biologics License Application (sBLA) that seeks to extend the use of Opdivo ...
Catch Bristol-Myers Squibb Co (BMY) Stock With Confidence
Bristol-Myers Squibb Co (NYSE:BMY) stock has had a rough 12-month period, down over 30% within that tine range. Compare that with the 10% performance of the iShares Nasdaq Biotechnology Index (ETF) (NASDAQ:IBB) - as a collective, they've ...
How Does Bristol-Myers Squibb Company (BMY) Stack Up Right Now?  StockNewsJournal
Fulton Bank N.A. Reduces Stake in Bristol-Myers Squibb Co (BMY)  Sports Perspectives
I Think Bristol-Myers Squibb Has Finally Bottomed
Bristol-Myers Squibb (NYSE:BMY) has grown over time to become my largest healthcare related holding. This isn't because of ... BMY is what I call a "tweener" type company, meaning it's a bit of a pharmaceutical and a bit of a biotech. BMY is not a ...
Today's Brokerage Rating: ZIOPHARM Oncology, Inc. (ZIOP), Bristol-Myers ...  StockNewsJournal
Bristol-Myers Squibb Company (BMY) And Its Technical Chart Is Now Center Stage  NY Stock News
Athena Global Investors LLC Buys Bristol-Myers Squibb Company, Sells Bank of ...
Reston, VA, based Investment company Athena Global Investors LLC buys Bristol-Myers Squibb Company, sells Bank of America Corporation, Citigroup Inc, General Motors Co, Chevron Corp, Cisco Systems Inc during the 3-months ended 2017-03-31, ...
Bristol-Myers Squibb Company (NYSE:BMY) Stock Valuation Summary
Bristol-Myers Squibb Company (NYSE:BMY) shares traded 0.2% up during most recent session to reach at the closing price of $54.21.
Bristol-Myers, Pfizer Made Faulty Blood Thinner, Suit Says  Law360 (subscription)
BMO Capital Markets Lowers Bristol-Myers Squibb Co (BMY) to Underperform  Sports Perspectives
CORRECTING and REPLACING Bristol-Myers Squibb to Hold Investor Teleconference ...
Bristol-Myers Squibb Company (NYSE:BMY) will host a teleconference on Sunday, June 4, 2017, at 7:30 p.m. EDT (6:30 p.m. CDT) to discuss company strategy and review data presented at the Annual Meeting of the American Society of Clinical Oncology ...
Bristol-Myers Squibb Company (NYSE:BMY) Quarterly Analytical Analysis  AppsforPCdaily
Digging Up the Facts on Bristol-Myers Squibb Company (BMY)  StockNewsJournal
Inside Bristol-Myers Squibb's Valuation after the 1Q17 Earnings
Headquartered in New York City, Bristol-Myers Squibb (BMY) is an American pharmaceutical company dealing with innovative medicines for patients with serious diseases in therapeutic areas including Virology, Oncology, Cardiovascular, and ...
Bristol-Myers Squibb Research Showcases Expansive Oncology Clinical ...  Business Wire (press release)
Bristol-Myers Squibb Company (BMY) Moves Lower on Volume Spike for May 18